CAPITAL HEALTH REGIONAL MEDICAL CTR
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $506K
- Transactions
- 191
- Companies
- 29
- Average per transaction
- $2,651
Who reported the payments
| Sebela Women's Health Inc. | $102,198 |
| CSL Behring | $92,632 |
| Mimedx Group, Inc. | $70,100 |
| Regeneron | $62,496 |
| Merck | $45,761 |
| Genentech, Inc. | $18,809 |
| AbbVie | $13,000 |
| Janssen Research & Development, LLC | $12,179 |
| Sumitomo Pharma America, Inc. | $10,569 |
| Bayer | $9,320 |
| Edwards Lifesciences | $8,750 |
| Johnson & Johnson | $8,406 |
| Olympus America Inc. | $8,357 |
| Array Biopharma Inc | $7,500 |
| Pfizer | $6,750 |
| Novocure Inc. | $5,500 |
| Astellas Pharma US Inc | $4,000 |
| CTI Biopharma Corp. | $3,500 |
| Sobi, Inc | $3,500 |
| Medtronic | $2,500 |
| Roche Diagnostics Corporation | $2,500 |
| Genmab U.S., Inc. | $2,000 |
| Stryker | $1,948 |
| Accuray Incorporated | $1,000 |
| Medline Industries LP | $761 |
| Baxter Healthcare | $740 |
| Biotronik Inc. | $693 |
| Eli Lilly | $685 |
| Siemens Medical Solutions USA, Inc. | $274 |